Group One Trading
LPCN icon

Group One Trading’s Lipocine LPCN Stock Holding History

Group One Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Sell
132
-30
-19% -$261 ﹤0.01% 7208
2025
Q4 		$1.3K Hold
162
– – ﹤0.01% 7653
2025
Q3 		$463 Hold
162
– – ﹤0.01% 8152
2025
Q2 		$512 Sell
162
-35
-18% -$114 ﹤0.01% 7656
2025
Q1 		$626 Hold
197
– – ﹤0.01% 7253
2024
Q4 		$961 Sell
197
-226
-53% -$1.15K ﹤0.01% 6897
2024
Q3 		$1.9K Buy
423
+407
+2,544% +$2.04K ﹤0.01% 6158
2024
Q2 		$132 Sell
16
-24
-60% -$150 ﹤0.01% 6541
2024
Q1 		$208 Sell
40
-12
-23% -$47 ﹤0.01% 6805
2023
Q4 		$144 Hold
52
– – ﹤0.01% 7182
2023
Q3 		$153 Hold
52
– – ﹤0.01% 7447
2023
Q2 		$260 Sell
52
-68
-57% -$320 ﹤0.01% 7442
2023
Q1 		$651 Buy
+120
New +$927 ﹤0.01% 6867
2021
Q2 		– Sell
-3,052
Closed -$71.8K – 8369
2021
Q1 		$78K Buy
+3,052
New +$88.1K ﹤0.01% 5871
2020
Q3 		– Sell
-2,209
Closed -$58.7K – 6349
2020
Q2 		$47K Buy
2,209
+283
+15% +$3.67K ﹤0.01% 4406
2020
Q1 		$16K Sell
1,926
-1,504
-44% -$11.9K ﹤0.01% 4351
2019
Q4 		$22K Buy
3,430
+3,158
+1,161% +$80.9K ﹤0.01% 4339
2019
Q3 		$13K Sell
272
-560
-67% -$22.5K ﹤0.01% 4513
2019
Q2 		$28K Hold
832
– – ﹤0.01% 4044
2019
Q1 		$33K Sell
832
-325
-28% -$9.97K ﹤0.01% 3790
2018
Q4 		$26K Sell
1,157
-236
-17% -$5.47K ﹤0.01% 3903
2018
Q3 		$33K Sell
1,393
-2,575
-65% -$63.3K ﹤0.01% 4195
2018
Q2 		$88K Buy
3,968
+213
+6% +$5.08K ﹤0.01% 3644
2018
Q1 		$98K Buy
+3,755
New +$105K ﹤0.01% 3259
2017
Q1 		– Sell
-296
Closed -$19.2K – 4829
2016
Q4 		$19K Buy
+296
New +$18.7K ﹤0.01% 3720

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Group One Trading's LPCN Position: Q1 2026 in Review

Group One Trading reduced its Lipocine (LPCN) stake by 19% in Q1 2026, selling an estimated $261 and leaving 132 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #7208.

Group One Trading first reported a position in LPCN in Q4 2016 and has held it in 25 quarters since. The position peaked at $98K in Q1 2018. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Group One Trading held 132 shares of Lipocine worth $1.05K as of Q1 2026.
  • Group One Trading sold 30 Lipocine shares in Q1 2026, an estimated $261.
  • Lipocine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7208 holding.
  • Group One Trading first reported a position in Lipocine in Q4 2016 and has held it in 25 quarters since.
  • Group One Trading's Lipocine position peaked at $98K in Q1 2018.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.